Plasma Pancreatic Polypeptide (PP)
36-amino-acid regulatory peptide synthesized by gamma-cells (PP cells) localized in the head of the pancreas, released under vagal cholinergic control.
Standard vs. Optimal Reference Rangespg/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
50 - 300 pg/mL (fasting)
General reference distribution across unselected commercial populations.
60 - 250 pg/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Suppresses postprandial pancreatic exocrine enzyme and bicarbonate secretion and inhibits gallbladder emptying.
Differential Diagnosis
Elevated Levels (PP High)
- •Pancreatic neuroendocrine tumors (PPoma)
- •Normal postprandial vagal cholinergic stimulation
- •Chronic renal failure
Low Levels (PP Low)
- •Autonomic diabetic neuropathy (blunted PP response to sham feeding or hypoglycemia)
- •Total pancreatectomy
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for PP
- Targeted organ system imaging or functional dynamic testing related to vagal cholinergic tone & pancreatic output
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Plasma Pancreatic Polypeptide - The New England Journal of Medicine (2021). PMID: 34190124
- [2]PP Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Plasma Pancreatic Polypeptide (PP) into overall healthspan optimization.